Birdwatch Note Rating
2023-05-20 01:19:08 UTC - HELPFUL
Rated by Participant: E9E1216A6501D0FB775DDCC53BB8326334C827FDAED70C961503BE92846F4DC9
Participant Details
Original Note:
The reactogenicity subset consisted of 8,183 persons. Severe disease subset was the entire cohort (N=43,355) The severe disease endpoint was 30-1 in favor of placebo for 96.7% reduction in 6 month follow up data https://www.nejm.org/doi/suppl/10.1056/NEJMoa2034577/suppl_file/nejmoa2034577_appendix.pdf https://www.nejm.org/doi/full/10.1056/nejmoa2110345
All Note Details